A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome

被引:44
作者
Clendenning, M. [1 ]
Senter, L. [1 ]
Hampel, H. [1 ]
Robinson, K. Lagerstedt [2 ]
Sun, S. [3 ]
Buchanan, D.
Walsh, M. D. [4 ]
Nilbert, M. [5 ]
Green, J. [6 ]
Potter, J. [7 ]
Lindblom, A. [2 ]
de la Chapelle, A. [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Ohio State Univ, Math Biosci Inst, Columbus, OH USA
[4] Queensland Inst Med Res, Familial Canc Lab, Herston, Qld 4006, Australia
[5] Lund Univ, Dept Oncol, Lund, Sweden
[6] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
10.1136/jmg.2007.056150
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: When compared to the other mismatch repair genes involved in Lynch syndrome, the identification of mutations within PMS2 has been limited (<2% of all identified mutations), yet the immunohistochemical analysis of tumour samples indicates that approximately 5% of Lynch syndrome cases are caused by PMS2. This disparity is primarily due to complications in the study of this gene caused by interference from pseudogene sequences. Methods: Using a recently developed method for detecting PMS2 specific mutations, we have screened 99 patients who are likely candidates for PMS2 mutations based on immunohistochemical analysis. Results: We have identified a frequently occurring frame-shift mutation (c.736_741del 6ins11) in 12 ostensibly unrelated Lynch syndrome patients (20% of patients we have identified with a deleterious mutation in PMS2, n = 61). These individuals all display the rare allele (population frequency <0.05) at a single nucleotide polymorphism (SNP) in exon 11, and have been shown to possess a short common haplotype, allowing us to calculate that the mutation arose around 1625 years ago (65 generations; 95% confidence interval 22 to 120). Conclusion: Ancestral analysis indicates that this mutation is enriched in individuals with British and Swedish ancestry. We estimate that there are >10 000 carriers of this mutation in the USA alone. The identification of both the mutation and the common haplotype in one Swedish control sample (n = 225), along with evidence that Lynch syndrome associated cancers are rarer than expected in the probands' families, would suggest that this is a prevalent mutation with reduced penetrance.
引用
收藏
页码:340 / 345
页数:6
相关论文
共 30 条
  • [1] Two PMS2 mutations in a Turcot syndrome family with small bowel cancers
    Agostini, M
    Tibiletti, MG
    Lucci-Cordisco, E
    Chiaravalli, A
    Morreau, H
    Furlan, D
    Boccuto, L
    Pucciarelli, S
    Capella, C
    Boiocchi, M
    Viel, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08) : 1886 - 1891
  • [2] Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
    Barkardottir, RB
    Sarantaus, L
    Arason, A
    Vehmanen, P
    Bendahl, PO
    Kainu, T
    Syrjäkoski, K
    Krahe, R
    Huusko, P
    Pyrhönen, S
    Holli, K
    Kallioniemi, OP
    Egilsson, V
    Kere, J
    Nevanlinna, H
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (10) : 773 - 779
  • [3] Long-range PCR facilitates the identification of PMS2-specific mutations
    Clendenning, M
    Hampel, H
    LaJeunesse, J
    Lindblom, A
    Lockman, J
    Nilbert, M
    Senter, L
    Sotamaa, K
    de la Chapelle, A
    [J]. HUMAN MUTATION, 2006, 27 (05) : 490 - 495
  • [4] PMS2 mutations in childhood cancer
    De Vos, M
    Hayward, BE
    Charlton, R
    Taylor, GR
    Glaser, AW
    Picton, S
    Cole, TR
    Maher, ER
    McKeown, CME
    Mann, JR
    Yates, JR
    Baralle, D
    Rankin, J
    Bonthron, DT
    Sheridan, E
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05): : 358 - 361
  • [5] Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome
    De Vos, M
    Hayward, BE
    Picton, S
    Sheridan, E
    Bonthron, DT
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (05) : 954 - 964
  • [6] DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
    Esteller, M
    Fraga, MF
    Guo, MZ
    Garcia-Foncillas, J
    Hedenfalk, I
    Godwin, AK
    Trojan, J
    Vaurs-Barrière, C
    Bignon, YJ
    Ramus, S
    Benitez, J
    Caldes, T
    Akiyama, Y
    Yuasa, Y
    Launonen, V
    Canal, MJ
    Rodriguez, R
    Capella, G
    Peinado, MA
    Borg, A
    Aaltonen, LA
    Ponder, BA
    Baylin, SB
    Herman, JG
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (26) : 3001 - 3007
  • [7] Estimating the age of rare disease mutations: the example of Triple-A syndrome
    Genin, E
    Tullio-Pelet, A
    Begeot, F
    Lyonnet, S
    Abel, L
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (06) : 445 - 449
  • [8] Isolated loss of PMS2 expression in colorectal cancers: Frequency, patient age, and familial aggregation
    Gill, S
    Lindor, NM
    Burgart, LJ
    Smalley, R
    Leontovich, O
    French, AJ
    Goldberg, RM
    Sargent, DJ
    Jass, JR
    Hopper, JL
    Jenkins, MA
    Young, J
    Barker, MA
    Walsh, MD
    Ruszkiewicz, AR
    Thibodeau, SN
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6466 - 6471
  • [9] Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
    Hampel, H
    Frankel, WL
    Martin, E
    Arnold, M
    Khanduja, K
    Kuebler, P
    Nakagawa, H
    Sotamaa, K
    Prior, TW
    Westman, J
    Panescu, J
    Fix, D
    Lockman, J
    Comeras, I
    de la Chapelle, A
    Ellison, C
    Melvin, S
    Winston, J
    Adeli, A
    Burak, W
    Chadwick, R
    Elkhatib, I
    Hemingway, T
    Jamieson, K
    Johnson, C
    LaJeunesse, J
    Liyanarachchi, S
    Rangel, P
    Soble, D
    Walker, M
    Wise, T
    Zhang, Y
    Schlanger, R
    Aguilar, P
    Hura, D
    Keith, J
    Kerner, B
    Lavalle, G
    Taylor, C
    Vara, T
    Zangmeister, J
    DeVictor, S
    Hines, L
    Lindsey, M
    Madhavan, J
    Padmanabhan, A
    Hamelberg, K
    Niemann, T
    Behrens, BC
    Blair, SC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18) : 1851 - 1860
  • [10] LOSS OF THE WILD-TYPE MLH1 GENE IS A FEATURE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER
    HEMMINKI, A
    PELTOMAKI, P
    MECKLIN, JP
    JARVINEN, H
    SALOVAARA, R
    NYSTROMLAHTI, M
    DELACHAPELLE, A
    AALTONEN, LA
    [J]. NATURE GENETICS, 1994, 8 (04) : 405 - 410